David Eansor, President-Protein Sciences at Bio-Techne, holds 16.71K shares in Marker Therapeutics (Ticker: MRKR), holds 2.12K shares in Bio-Techne (Ticker: TECH), holds 6.30K shares in Cambrex (Ticker: CBM). Most recently, David Eansor Bought ― shares of Marker Therapeutics on Jun 08, 2023 for an estimated value of 249.99K.